These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2019311)

  • 1. Cyclosporin A and its metabolites, distribution in blood and tissues.
    Akagi H; Reynolds A; Hjelm M
    J Int Med Res; 1991; 19(1):1-18. PubMed ID: 2019311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae.
    Tropschug M; Barthelmess IB; Neupert W
    Nature; 1989 Dec 21-28; 342(6252):953-5. PubMed ID: 2531848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of cyclosporin A. I. Study in freshly isolated rabbit hepatocytes.
    Fabre G; Bertault-Peres P; Fabre I; Maurel P; Just S; Cano JP
    Drug Metab Dispos; 1987; 15(3):384-90. PubMed ID: 2886316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase.
    Harding MW; Galat A; Uehling DE; Schreiber SL
    Nature; 1989 Oct; 341(6244):758-60. PubMed ID: 2477715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy.
    Kallen J; Spitzfaden C; Zurini MG; Wider G; Widmer H; Wüthrich K; Walkinshaw MD
    Nature; 1991 Sep; 353(6341):276-9. PubMed ID: 1896075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
    Fischer G; Wittmann-Liebold B; Lang K; Kiefhaber T; Schmid FX
    Nature; 1989 Feb; 337(6206):476-8. PubMed ID: 2492638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A: new insights for cell biologists and biochemists.
    Hohman RJ; Hultsch T
    New Biol; 1990 Aug; 2(8):663-72. PubMed ID: 2282365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.
    Lemaire M; Tillement JP
    J Pharm Pharmacol; 1982 Nov; 34(11):715-8. PubMed ID: 6129301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
    Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
    Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin.
    Takahashi N; Hayano T; Suzuki M
    Nature; 1989 Feb; 337(6206):473-5. PubMed ID: 2644542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of blood components on the tissue uptake indices of cyclosporin in rats.
    Lemaire M; Pardridge WM; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Feb; 244(2):740-3. PubMed ID: 3346845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin.
    Watanabe S; Tsuruoka S; Vijayakumar S; Fischer G; Zhang Y; Fujimura A; Al-Awqati Q; Schwartz GJ
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F40-7. PubMed ID: 15353404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular penetration of cyclosporin A. The rabbit eye.
    BenEzra D; Maftzir G
    Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1362-6. PubMed ID: 2365566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
    Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
    J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.
    Siekierka JJ; Hung SH; Poe M; Lin CS; Sigal NH
    Nature; 1989 Oct; 341(6244):755-7. PubMed ID: 2477714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescence polarization-based assay for peptidyl prolyl cis/trans isomerase cyclophilin A.
    Liu Y; Jiang J; Richardson PL; Reddy RD; Johnson DD; Kati WM
    Anal Biochem; 2006 Sep; 356(1):100-7. PubMed ID: 16737676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cyclosporine A uptake in human erythrocytes.
    Reichel C; von Falkenhausen M; Brockmeier D; Dengler HJ
    Eur J Clin Pharmacol; 1994; 46(5):417-9. PubMed ID: 7957535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature-dependent binding of cyclosporine to an erythrocyte protein.
    Agarwal RP; Threatte GA; McPherson RA
    Clin Chem; 1987 Apr; 33(4):481-5. PubMed ID: 3549056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.
    Hong F; Lee J; Song JW; Lee SJ; Ahn H; Cho JJ; Ha J; Kim SS
    FASEB J; 2002 Oct; 16(12):1633-5. PubMed ID: 12207006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.